Carbenoxolone sodium is a synthetic derivative of glycyrrhizin and inhibitor connexins and 11β-HSD. It is used to treat ulcers and inflammation but also displays other biological activities. It suppresses gap junction communication, delays onset of EAE in vivo, and decreases infarct volume in models of cerebral ischemia/reperfusion.
Statement:
->>Products covered by valid patents are not offered or supplied for commercial use.
->>Products currently covered by valid US Patents are offered for laboratory R&D use in accordance with 35 USC 271(e)+A13(1).
->>Any patent infringement and resulting liability is solely at buyer's risk.
->>Our products are only raw materials for drugs or industry, can't be used for human or animals directly.